Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer

Published:2015-09 Issue:9 Volume:10 Page:1319-1327
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Vansteenkiste Johan F.,Canon Jean-Luc,De Braud Filippo,Grossi Francesco,De Pas Tommaso,Gray Jhanelle E.,Su Wu-Chou,Felip Enriqueta,Yoshioka Hiroshige,Gridelli Cesare,Dy Grace K.,Thongprasert Sumitra,Reck Martin,Aimone Paola,Vidam Gena Atalla,Roussou Pantelia,Wang Ying A.,Di Tomaso Emmanuelle,Soria Jean-Charles

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. European cancer mortality predictions for the year 2014;Malvezzi;Ann Oncol,2014

2. SEER cancer statistics review, 1975–2008;Howlader;Bethesda MD Natl Cancer Inst,2011

3. Treatment paradigms for patients with metastatic non-small-cell lung cancer: First-, second-, and third-line;Leighl;Curr Oncol,2012

4. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

2. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis;Toxicology in Vitro;2024-05

3. Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments;Drugs;2024-04-16

4. PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities;Pharmacological Research;2024-04

5. Inhibition of PI3K/AKT signaling using BKM120 reduced the proliferation and migration potentials of colorectal cancer cells and enhanced cisplatin-induced cytotoxicity;Molecular Biology Reports;2024-03-14